Umeclidinium bromide is a quaternary ammonium salt that is the bromide salt of umeclidinium. Used in combination with vilanterol for long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease. Among its listed roles, it functions as a muscarinic antagonist. It is a quaternary ammonium salt and an organic bromide salt. It includes a umeclidinium. It is grouped under the following drug class(es): Anticholinergics and Bronchodilators. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Anoro Ellipta and Incruse Ellipta. Its PubChem CID is 11519070.
Umeclidinium bromide
| CAS No | 869113-09-7 |
|---|---|
| Molecular Formula | C29H34BrNO2 |
| Molecular Weight | 508.50 g/mol |
| Synonyms | diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol;bromide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Umeclidinium bromide is a quaternary ammonium salt that is the bromide salt of umeclidinium. Used in combination with vilanterol for long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.
The listed CAS number is 869113-09-7.
The listed molecular formula is C29H34BrNO2.
The listed molecular weight is 508.50 g/mol.
diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol;bromide.
The source lists Anoro Ellipta and Incruse Ellipta.